Immune Check Point Inhibitors
Immune Check Point Inhibitors market is segmented by players, region (country), by Type and by Ap ... Read More
Global Imatinib Drug Market Insights and Forecast to 2031
1 Study Coverage
1.1 Imatinib Drug Product Introduction
1.2 Market by Type
1.2.1 Global Imatinib Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsules
1.3 Market by Application
1.3.1 Global Imatinib Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Chronic Myelogenous Leukemia
1.3.3 Gastrointestinal Stromal Tumors
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Imatinib Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Imatinib Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Imatinib Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Imatinib Drug Sales by Region
2.4.1 Global Imatinib Drug Sales by Region (2017-2022)
2.4.2 Global Sales Imatinib Drug by Region (2023-2028)
2.5 Global Imatinib Drug Revenue by Region
2.5.1 Global Imatinib Drug Revenue by Region (2017-2022)
2.5.2 Global Imatinib Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Imatinib Drug Sales by Manufacturers
3.1.1 Global Top Imatinib Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Imatinib Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Imatinib Drug in 2021
3.2 Global Imatinib Drug Revenue by Manufacturers
3.2.1 Global Imatinib Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Imatinib Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Imatinib Drug Revenue in 2021
3.3 Global Imatinib Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Imatinib Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Imatinib Drug Sales by Type
4.1.1 Global Imatinib Drug Historical Sales by Type (2017-2022)
4.1.2 Global Imatinib Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Imatinib Drug Sales Market Share by Type (2017-2028)
4.2 Global Imatinib Drug Revenue by Type
4.2.1 Global Imatinib Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Imatinib Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Imatinib Drug Revenue Market Share by Type (2017-2028)
4.3 Global Imatinib Drug Price by Type
4.3.1 Global Imatinib Drug Price by Type (2017-2022)
4.3.2 Global Imatinib Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Imatinib Drug Sales by Application
5.1.1 Global Imatinib Drug Historical Sales by Application (2017-2022)
5.1.2 Global Imatinib Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Imatinib Drug Sales Market Share by Application (2017-2028)
5.2 Global Imatinib Drug Revenue by Application
5.2.1 Global Imatinib Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Imatinib Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Imatinib Drug Revenue Market Share by Application (2017-2028)
5.3 Global Imatinib Drug Price by Application
5.3.1 Global Imatinib Drug Price by Application (2017-2022)
5.3.2 Global Imatinib Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Imatinib Drug Market Size by Type
6.1.1 North America Imatinib Drug Sales by Type (2017-2028)
6.1.2 North America Imatinib Drug Revenue by Type (2017-2028)
6.2 North America Imatinib Drug Market Size by Application
6.2.1 North America Imatinib Drug Sales by Application (2017-2028)
6.2.2 North America Imatinib Drug Revenue by Application (2017-2028)
6.3 North America Imatinib Drug Market Size by Country
6.3.1 North America Imatinib Drug Sales by Country (2017-2028)
6.3.2 North America Imatinib Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Imatinib Drug Market Size by Type
7.1.1 Europe Imatinib Drug Sales by Type (2017-2028)
7.1.2 Europe Imatinib Drug Revenue by Type (2017-2028)
7.2 Europe Imatinib Drug Market Size by Application
7.2.1 Europe Imatinib Drug Sales by Application (2017-2028)
7.2.2 Europe Imatinib Drug Revenue by Application (2017-2028)
7.3 Europe Imatinib Drug Market Size by Country
7.3.1 Europe Imatinib Drug Sales by Country (2017-2028)
7.3.2 Europe Imatinib Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Imatinib Drug Market Size by Type
8.1.1 Asia Pacific Imatinib Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Imatinib Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Imatinib Drug Market Size by Application
8.2.1 Asia Pacific Imatinib Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Imatinib Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Imatinib Drug Market Size by Region
8.3.1 Asia Pacific Imatinib Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Imatinib Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Imatinib Drug Market Size by Type
9.1.1 Latin America Imatinib Drug Sales by Type (2017-2028)
9.1.2 Latin America Imatinib Drug Revenue by Type (2017-2028)
9.2 Latin America Imatinib Drug Market Size by Application
9.2.1 Latin America Imatinib Drug Sales by Application (2017-2028)
9.2.2 Latin America Imatinib Drug Revenue by Application (2017-2028)
9.3 Latin America Imatinib Drug Market Size by Country
9.3.1 Latin America Imatinib Drug Sales by Country (2017-2028)
9.3.2 Latin America Imatinib Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Imatinib Drug Market Size by Type
10.1.1 Middle East and Africa Imatinib Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Imatinib Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Imatinib Drug Market Size by Application
10.2.1 Middle East and Africa Imatinib Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Imatinib Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Imatinib Drug Market Size by Country
10.3.1 Middle East and Africa Imatinib Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Imatinib Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Imatinib Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Glenmark Pharmaceuticals Ltd.
11.2.1 Glenmark Pharmaceuticals Ltd. Corporation Information
11.2.2 Glenmark Pharmaceuticals Ltd. Overview
11.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Glenmark Pharmaceuticals Ltd. Recent Developments
11.3 Sun Pharmaceuticals
11.3.1 Sun Pharmaceuticals Corporation Information
11.3.2 Sun Pharmaceuticals Overview
11.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sun Pharmaceuticals Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sun Pharmaceuticals Recent Developments
11.4 Actavis Generics
11.4.1 Actavis Generics Corporation Information
11.4.2 Actavis Generics Overview
11.4.3 Actavis Generics Imatinib Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Actavis Generics Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Actavis Generics Recent Developments
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Corporation Information
11.5.2 Dr. Reddy's Laboratories Overview
11.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dr. Reddy's Laboratories Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dr. Reddy's Laboratories Recent Developments
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.6.2 Teva Pharmaceutical Industries Ltd. Overview
11.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.7 Sanofi S.A.
11.7.1 Sanofi S.A. Corporation Information
11.7.2 Sanofi S.A. Overview
11.7.3 Sanofi S.A. Imatinib Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sanofi S.A. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi S.A. Recent Developments
11.8 Cipla Inc.
11.8.1 Cipla Inc. Corporation Information
11.8.2 Cipla Inc. Overview
11.8.3 Cipla Inc. Imatinib Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cipla Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cipla Inc. Recent Developments
11.9 Apotex Inc.
11.9.1 Apotex Inc. Corporation Information
11.9.2 Apotex Inc. Overview
11.9.3 Apotex Inc. Imatinib Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Apotex Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Apotex Inc. Recent Developments
11.10 Mylan Pharms Inc.
11.10.1 Mylan Pharms Inc. Corporation Information
11.10.2 Mylan Pharms Inc. Overview
11.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mylan Pharms Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Pharms Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Imatinib Drug Industry Chain Analysis
12.2 Imatinib Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Imatinib Drug Production Mode & Process
12.4 Imatinib Drug Sales and Marketing
12.4.1 Imatinib Drug Sales Channels
12.4.2 Imatinib Drug Distributors
12.5 Imatinib Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Imatinib Drug Industry Trends
13.2 Imatinib Drug Market Drivers
13.3 Imatinib Drug Market Challenges
13.4 Imatinib Drug Market Restraints
14 Key Findings in The Global Imatinib Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Imatinib Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsules
Table 4. Global Imatinib Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Imatinib Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Imatinib Drug Sales by Region (2017-2022) & (K Units)
Table 7. Global Imatinib Drug Sales Market Share by Region (2017-2022)
Table 8. Global Imatinib Drug Sales by Region (2023-2028) & (K Units)
Table 9. Global Imatinib Drug Sales Market Share by Region (2023-2028)
Table 10. Global Imatinib Drug Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Imatinib Drug Revenue Market Share by Region (2017-2022)
Table 12. Global Imatinib Drug Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Imatinib Drug Revenue Market Share by Region (2023-2028)
Table 14. Global Imatinib Drug Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Imatinib Drug Sales Share by Manufacturers (2017-2022)
Table 16. Global Imatinib Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Imatinib Drug Revenue Share by Manufacturers (2017-2022)
Table 18. Imatinib Drug Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Imatinib Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Imatinib Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drug as of 2021)
Table 21. Imatinib Drug Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Imatinib Drug Product Offered
Table 23. Date of Manufacturers Enter into Imatinib Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 26. Global Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 27. Global Imatinib Drug Sales Share by Type (2017-2022)
Table 28. Global Imatinib Drug Sales Share by Type (2023-2028)
Table 29. Global Imatinib Drug Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Imatinib Drug Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Imatinib Drug Revenue Share by Type (2017-2022)
Table 32. Global Imatinib Drug Revenue Share by Type (2023-2028)
Table 33. Imatinib Drug Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Imatinib Drug Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 36. Global Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 37. Global Imatinib Drug Sales Share by Application (2017-2022)
Table 38. Global Imatinib Drug Sales Share by Application (2023-2028)
Table 39. Global Imatinib Drug Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Imatinib Drug Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Imatinib Drug Revenue Share by Application (2017-2022)
Table 42. Global Imatinib Drug Revenue Share by Application (2023-2028)
Table 43. Imatinib Drug Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Imatinib Drug Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 46. North America Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 47. North America Imatinib Drug Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Imatinib Drug Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 50. North America Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 51. North America Imatinib Drug Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Imatinib Drug Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Imatinib Drug Sales by Country (2017-2022) & (K Units)
Table 54. North America Imatinib Drug Sales by Country (2023-2028) & (K Units)
Table 55. North America Imatinib Drug Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Imatinib Drug Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 58. Europe Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 59. Europe Imatinib Drug Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Imatinib Drug Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 62. Europe Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 63. Europe Imatinib Drug Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Imatinib Drug Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Imatinib Drug Sales by Country (2017-2022) & (K Units)
Table 66. Europe Imatinib Drug Sales by Country (2023-2028) & (K Units)
Table 67. Europe Imatinib Drug Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Imatinib Drug Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Imatinib Drug Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Imatinib Drug Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Imatinib Drug Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Imatinib Drug Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Imatinib Drug Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Imatinib Drug Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Imatinib Drug Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Imatinib Drug Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Imatinib Drug Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Imatinib Drug Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Imatinib Drug Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Imatinib Drug Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Imatinib Drug Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Imatinib Drug Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Imatinib Drug Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Imatinib Drug Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Imatinib Drug Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Imatinib Drug Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Imatinib Drug Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Imatinib Drug Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Imatinib Drug Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Imatinib Drug Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Imatinib Drug Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Imatinib Drug Revenue by Country (2023-2028) & (US$ Million)
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Major Businesses
Table 107. Novartis Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Novartis Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Novartis Recent Developments
Table 110. Glenmark Pharmaceuticals Ltd. Corporation Information
Table 111. Glenmark Pharmaceuticals Ltd. Description and Major Businesses
Table 112. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Glenmark Pharmaceuticals Ltd. Recent Developments
Table 115. Sun Pharmaceuticals Corporation Information
Table 116. Sun Pharmaceuticals Description and Major Businesses
Table 117. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Sun Pharmaceuticals Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sun Pharmaceuticals Recent Developments
Table 120. Actavis Generics Corporation Information
Table 121. Actavis Generics Description and Major Businesses
Table 122. Actavis Generics Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Actavis Generics Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Actavis Generics Recent Developments
Table 125. Dr. Reddy's Laboratories Corporation Information
Table 126. Dr. Reddy's Laboratories Description and Major Businesses
Table 127. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Dr. Reddy's Laboratories Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Dr. Reddy's Laboratories Recent Developments
Table 130. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 131. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
Table 132. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 135. Sanofi S.A. Corporation Information
Table 136. Sanofi S.A. Description and Major Businesses
Table 137. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Sanofi S.A. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Sanofi S.A. Recent Developments
Table 140. Cipla Inc. Corporation Information
Table 141. Cipla Inc. Description and Major Businesses
Table 142. Cipla Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Cipla Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Cipla Inc. Recent Developments
Table 145. Apotex Inc. Corporation Information
Table 146. Apotex Inc. Description and Major Businesses
Table 147. Apotex Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Apotex Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Apotex Inc. Recent Developments
Table 150. Mylan Pharms Inc. Corporation Information
Table 151. Mylan Pharms Inc. Description and Major Businesses
Table 152. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Mylan Pharms Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Mylan Pharms Inc. Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Imatinib Drug Distributors List
Table 158. Imatinib Drug Customers List
Table 159. Imatinib Drug Market Trends
Table 160. Imatinib Drug Market Drivers
Table 161. Imatinib Drug Market Challenges
Table 162. Imatinib Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Imatinib Drug Product Picture
Figure 3. Global Imatinib Drug Market Share by Type in 2021 & 2028
Figure 3. Tablets Product Picture
Figure 4. Capsules Product Picture
Figure 5. Global Imatinib Drug Market Share by Application in 2021 & 2028
Figure 6. Chronic Myelogenous Leukemia
Figure 7. Gastrointestinal Stromal Tumors
Figure 8. Others
Figure 9. Imatinib Drug Report Years Considered
Figure 10. Global Imatinib Drug Sales 2017-2028 (K Units)
Figure 11. Global Imatinib Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Imatinib Drug Revenue 2017-2028 (US$ Million)
Figure 13. Global Imatinib Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Imatinib Drug Sales Market Share by Region (2017-2022)
Figure 15. Global Imatinib Drug Sales Market Share by Region (2023-2028)
Figure 16. North America Imatinib Drug Sales YoY (2017-2028) & (K Units)
Figure 17. North America Imatinib Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Imatinib Drug Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Imatinib Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Imatinib Drug Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Imatinib Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Imatinib Drug Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Imatinib Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Imatinib Drug Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Imatinib Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Imatinib Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Imatinib Drug in the World: Market Share by Imatinib Drug Revenue in 2021
Figure 28. Global Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 30. Global Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 31. Global Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 32. Global Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 33. North America Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 34. North America Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 35. North America Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 36. North America Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 37. North America Imatinib Drug Sales Share by Country (2017-2028)
Figure 38. North America Imatinib Drug Revenue Share by Country (2017-2028)
Figure 39. U.S. Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 42. Europe Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 43. Europe Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 44. Europe Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 45. Europe Imatinib Drug Sales Share by Country (2017-2028)
Figure 46. Europe Imatinib Drug Revenue Share by Country (2017-2028)
Figure 47. Germany Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 48. France Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Imatinib Drug Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Imatinib Drug Revenue Share by Region (2017-2028)
Figure 58. China Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 61. India Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 69. Latin America Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 71. Latin America Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Imatinib Drug Sales Share by Country (2017-2028)
Figure 73. Latin America Imatinib Drug Revenue Share by Country (2017-2028)
Figure 74. Mexico Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Imatinib Drug Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Imatinib Drug Revenue Share by Country (2017-2028)
Figure 83. Turkey Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 86. Imatinib Drug Value Chain
Figure 87. Imatinib Drug Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis Glenmark Pharmaceuticals Ltd. Sun Pharmaceuticals Actavis Generics Dr. Reddy's Laboratories Teva Pharmaceutical Industries Ltd. Sanofi S.A. Cipla Inc. Apotex Inc. Mylan Pharms Inc.